Michael T. Pykosz Net Worth

The estimated Net Worth of Michael T Pykosz is at least $353 Milion dollars as of 11 August 2022. Mr Pykosz owns over 15 units of Oak Street Health stock worth over $280,248,501 and over the last 4 years he sold OSH stock worth over $71,671,406. In addition, he makes $983,419 as Chairman & CEO at Oak Street Health.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Mr Pykosz OSH stock SEC Form 4 insiders trading

Mr has made over 19 trades of the Oak Street Health stock since 2020, according to the Form 4 filled with the SEC. Most recently he sold 15 units of OSH stock worth $440 on 11 August 2022.

The largest trade he's ever made was selling 444,750 units of Oak Street Health stock on 7 December 2020 worth over $20,458,500. On average, Mr trades about 62,302 units every 25 days since 2020. As of 11 August 2022 he still owns at least 7,185,859 units of Oak Street Health stock.

You can see the complete history of Mr Pykosz stock trades at the bottom of the page.

Mr. Michael T. Pykosz biography

Michael T. Pykosz is the Chairman & CEO at Oak Street Health.

What is the salary of Mr Pykosz?

As the Chairman & CEO of Oak Street Health, the total compensation of Mr Pykosz at Oak Street Health is $983,419. There are 5 executives at Oak Street Health getting paid more, with Keiran Wulff having the highest compensation of $1,960,490.

How old is Mr Pykosz?

Mr Pykosz is 39, he's been the Chairman & CEO of Oak Street Health since . There are 13 older and 3 younger executives at Oak Street Health. The oldest executive at Oak Street Health, Inc. is Richard Lee, 69, who is the Independent Non-Executive Chairman of the Board.

What's Mr Pykosz's mailing address?

Michael's mailing address filed with the SEC is C/O OAK STREET HEALTH, INC., 30 W. MONROE STREET, SUITE 1200, CHICAGO, IL, 60603.

Insiders trading at Oak Street Health

Over the last 37 years, insiders at Oak Street Health have traded over $1,900,826,827 worth of Oak Street Health stock. The most active insiders traders include Partners Lp Newlight Harbou..., Atlantic, L.P.General Atlan... a Geoffrey M Price. On average, Oak Street Health executives and independent directors trade stock every 84 days with the average trade being worth of $10,310,586. The most recent stock trade was executed by Geoffrey M Price on 18 April 2023, trading 50,000 units of OSH stock currently worth $1,050,000.

What does Oak Street Health do?

Oak Street Health, Inc., together with its subsidiaries, offers healthcare services to the patients in the United States. The company operates primary care centers for Medicare beneficiaries. As of December 31, 2020, it operated 79 centers in Illinois, Indiana, Michigan, Mississippi, New York, North Carolina, Ohio, Pennsylvania, Rhode Island, Tennessee, and Texas. The company was founded in 2012 and is headquartered in Chicago, Illinois.

Complete history of Mr Pykosz stock trades at Oak Street Health

Oak Street Health executives and stock owners

Oak Street Health executives and other stock owners filed with the SEC include:

• Keiran Wulff,
  Managing Director, Executive Director
• Stephen Gardiner,
  Chief Financial Officer
• Michael Drew,
  Executive Vice President - Corporate, General Counsel, Group Secretary
• Ian Munro,
  Executive Vice President - Portfolio Management, Gas and Marketing
• Elizabeth White,
  Executive Vice President - Sustainability and Technology
• Michael T. Pykosz,
  Chairman & CEO
• Geoffrey M. Price,
  COO & Director
• Dr. Griffin R. Myers M.D.,
  Chief Medical Officer & Director
• Dr. Griffin R. Myers,
  Chief Medical Officer & Director
• Richard Lee,
  Independent Non-Executive Chairman of the Board
• Bart Lismont,
  Executive Vice President - PNG Development and Operations
• Agu Kantsler,
  Independent Non-Executive Director
• Eileen Doyle,
  Independent Non-Executive Director
• Fiona Harris,
  Independent Non-Executive Director
• Bakheet Al Katheeri,
  Non-Executive Director
• Susan Cunningham,
  Independent Non-Executive Director
• Kostas Constantinou,
  Independent Non-Executive Director
• Erica Frank,
  VP of PR
• Sarah Cluck,
  Head of Investor Relations
• Dr. Rafe Petty,
  Division Pres of IN/MI/NC/OH
• James J. Chow,
  Pres of Managed Care Operations
• Cynthia Hiskes,
  Chief HR Officer
• Robert Guenthner,
  Chief Legal Officer & Sec.
• Jason Van den Eeden,
  Chief Technology Officer
• Timothy M. Cook,
  Chief Financial Officer
• Brian Clem,
  Pres
• Partners Lp Newlight Harbou...,
  
• Robert Guenthner,
  Chief Legal Officer
• Cynthia Hiskes,
  Chief Human Resources Officer
• James J Chow,
  Chief Managed Care Officer
• Tamara Jurgenson,
  Chief Growth Officer
• Julie D Klapstein,
  Director
• Cheryl Dorsey,
  Director
• Paul B. K. Kusserow,
  Director
• Atlantic, L.P.General Atlan...,
  
• Mohit Kaushal,
  Director
• Regina M. Benjamin,
  Director
• Geoffrey M Price,
  Chief Innovation Officer
• Michael T Pykosz,
  Chief Executive Officer
• Brian Clem,
  Chief Operating Officer
• Griffin Myers,
  Chief Medical Officer
• Timothy M Cook,
  Chief Financial Officer
• Kim Keck,
  Director